STING induces ZBP1-mediated necroptosis independently of TNFR1 and FADD.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40834903.
- Also identified by DOI 10.1038/s41586-025-09536-4 and PMC identifier 12629989.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Conditional deletion of caspase-8 in mouse epidermal keratinocytes (Casp8<sup>E-KO</sup>) causes necroptosis-driven lethal dermatitis<sup>1-7</sup>. Here we find that the loss of Casp8 leads to an accumulation of cytosolic DNA that is responsible for the activation of a cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING)-mediated transcriptional program. Genetic and biochemical evidence indicate that STING upregulates both Z-DNA-binding protein 1 (ZBP1) and mixed lineage kinase domain-like pseudokinase. Combined caspase-8-deficiency- and STING-activation-driven accumulation of Z-nucleic acids activates ZBP1 and triggers the formation of a ZBP1-RIPK1-RIPK3 complex independently of the FADD-RIPK1-RIPK3 complex, enabling execution of necroptosis. Genetically, we reveal a functional overlap between STING and ZBP1 as drivers of lethal dermatitis independently of tumour necrosis factor receptor 1 (TNFR1), identifying an aetiology of necroptotic inflammation. As gain-of-function mutations in human STING cause STING-associated vasculopathy with onset in infancy (SAVI), we assessed the role of STING-induced necroptosis in SAVI's aetiology. Chronic activation of STING in patients orchestrates a necroptotic transcriptional program that is confirmed in the Sting1<sup>N153S</sup> SAVI preclinical mouse model in which immune-cell-driven pathology and lethality are rescued by receptor-interacting serine/threonine-protein kinase 3 (Ripk3) co-deletion. These findings establish STING-driven ZBP1-mediated necroptosis as a central pathogenic mechanism in both caspase-8-deficient inflammation and SAVI and suggest that targeting the ZBP1-RIPK3-MLKL axis holds therapeutic potential for interferonopathies characterized by excessive necroptosis.
Medical subject headings
- Necroptosis
- Fas-Associated Death Domain Protein
- Membrane Proteins
- Receptors, Tumor Necrosis Factor, Type I
- RNA-Binding Proteins
- DNA-Binding Proteins